Compare Globus Medical Inc. Class A Common Stock (GMED) vs Garrett Motion Inc. Common Stock (GTX) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Garrett Motion (GTX) trades at $25.78, showing minimal daily movement with a 0.08% gain. The stock exhibits bearish technical signals despite strong fundamental performance, including three consecutive quarterly earnings beats and improving profit margins. Recent news highlights the company's leadership in turbocharging and electrification technologies, with Q3 2026 results expected on October 29th. Institutional activity shows significant positions from BlackRock and Deutsche Bank, while analyst consensus remains positive with a $38 price target representing 47% upside potential.

GTX presents a compelling value opportunity with attractive valuation multiples (P/E 14.16, P/S 1.35) and consistent earnings outperformance. However, technical weakness and competitive pressures in automotive technology create near-term headwinds. The upcoming Q3 earnings report on October 29th will be crucial for validating the company's raised 2026 outlook and momentum trajectory.